Clinical Trials Directory

Trials / Completed

CompletedNCT02595463

Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients

Intravenous Lidocaine to Decrease Postoperative Pain in Pediatric Patients Undergoing Tonsillectomy: A Randomized, Double Blind, Placebo Controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
Sex
All
Age
4 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether giving lidocaine intravenously during and after a tonsillectomy surgery is effective in decreasing postoperative pain.

Detailed description

The purpose of this study is to determine whether giving lidocaine intravenously during and after a tonsillectomy surgery is effective in decreasing postoperative pain when compared to placebo. Participants will be in one of two arms. Those in Arm 1 will receive a lidocaine bolus and infusion throughout the initial recovery period while those in Arm 2 will receive an equal volume of normal saline. Subjects will be monitored and assessed for pain during their time in the hospital and followed up on at home for a week after the surgery. Primary outcomes will be measure of pain. Secondary outcome measures will include pain medication use, emergence delirium, incidence of laryngospasm, and side effects.

Conditions

Interventions

TypeNameDescription
DRUGLidocaineIntraoperative dose of intravenous lidocaine followed by an infusion until discharge from the initial recovery period.
DRUGSalineIntraoperative dose of saline followed by an infusion until discharge from the initial recovery period.

Timeline

Start date
2015-11-01
Primary completion
2024-06-05
Completion
2024-07-05
First posted
2015-11-03
Last updated
2024-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02595463. Inclusion in this directory is not an endorsement.